John P. Leonard – författare
Visar alla böcker från författaren John P. Leonard. Handla med fri frakt och snabb leverans.
5 produkter
Wintrobe's Clinical Hematology: Print + eBook with Multimedia
Av Robert T. Means, Daniel A. Arber m. fl.
Inbunden, 2023
4520 kr
Lägg i varukorg
Selected as a Doody’s Essential Title for 2025!Comprehensive in scope and thoroughly up to date, Wintrobe’s Clinical Hematology, 15th Edition, combines the biology and pathophysiology of hematology as well as the diagnosis and treatment of commonly encountered hematological disorders. …
Mantle Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North America
Inbunden, 2020
1091 kr
Lägg i varukorg
This issue of Hematology/Oncology Clinics, Guest Edited by Dr. John P. Leonard, is devoted to Mantle Cell Lymphoma. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: Molecular …
Hodgkin's and Non-Hodgkin's Lymphoma
Av John P. Leonard, Morton Coleman
Inbunden, 2006
1689 kr
Lägg i varukorg
Over recent years, there has been a dramatic increase in knowledge of the biology of the lymphomas which has been accompanied by the emergence of new treatments that offer both improvements in efficacy and reduction in toxicity. Molecular profiling of tumor tissue and other new advances have led to …
Hodgkin's and Non-Hodgkin's Lymphoma
Av Morton Coleman, John P. Leonard
E-bok, 2008
1634 kr
Lägg i varukorg
Over recent years, there has been a dramatic increase in knowledge of the biology of the lymphomas which has been accompanied by the emergence of new treatments that offer both improvements in efficacy and reduction in toxicity. Molecular profiling of tumor tissue and other new advances have led to …
Hodgkin's and Non-Hodgkin's Lymphoma
Av John P. Leonard, Morton Coleman
Häftad, 2014
1243 kr
Lägg i varukorg
Over recent years, there has been a dramatic increase in knowledge of the biology of the lymphomas which has been accompanied by the emergence of new treatments that offer both improvements in efficacy and reduction in toxicity. Molecular profiling of tumor tissue and other new advances have led to …
